Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Columbia University
Columbia University
Juno Therapeutics, a Subsidiary of Celgene
Fate Therapeutics
University of Arizona
Incyte Corporation
Incyte Corporation
PrECOG, LLC.
Emory University
Incyte Corporation
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Insel Gruppe AG, University Hospital Bern
Polish Lymphoma Research Group
German CLL Study Group
German CLL Study Group
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
St. Petersburg State Pavlov Medical University
Damanhour University
University of Giessen
University of Giessen
AbbVie
Corewell Health West
M.D. Anderson Cancer Center
St. Petersburg State Pavlov Medical University
Wake Forest University Health Sciences
Washington University School of Medicine
Hoffmann-La Roche
Eastern Cooperative Oncology Group
University of Wisconsin, Madison
Teva Branded Pharmaceutical Products R&D, Inc.
Brown University
Hoffmann-La Roche
Hoffmann-La Roche
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
Arbeitsgemeinschaft medikamentoese Tumortherapie
Oxford University Hospitals NHS Trust
Ohio State University Comprehensive Cancer Center
SWOG Cancer Research Network
Seoul National University Hospital
SymBio Pharmaceuticals
Aptevo Therapeutics
Eagle Pharmaceuticals, Inc.
St. Petersburg State Pavlov Medical University
Hoffmann-La Roche